688266.SH
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 87.79
−6.61%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 40.24x
- P/E 2027E
- 57.77x
- P/E 2028E
- 42.88x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- -142.62x
- PEG TTM
- —
- Price / book
- 13.51x
- Price / sales
- 14.40x
- Price / cash flow
- 27.35x
Enterprise value
- Enterprise value
- —
- EV / sales
- —
- EV / EBITDA
- —
- EV / EBIT
- —
- Market cap
- CNY 23.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026